Found 14 matching trials
A Study to Test Inavolisib Treatments in Participants With Early-Stage, PIK3CA-Mutated Breast Cancer
PHASE2This study will evaluate the safety and efficacy of inavolisib combination ...
Location
Los Angeles Cancer Network
Neoadjuvant and Adjuvant Ribociclib and ET for Clinically High-risk ER+ and HER2- Breast Cancer
PHASE2This is an open-label, multicenter international trial in men and women wit...
Status
Active Not Recruiting
Location
Sainte Catherine - Institut du Cancer Avignon Provence
Trastuzumab Deruxtecan Versus Standard Neoadjuvant Treatment for HER2-positive Breast Cancer
PHASE2The goal of this clinical trial is to compare trastuzumab deruxtecan (T-DXd...
Location
Skåne University Hospital
A Randomized Study Comparing the Immune Modulation Effect of Ribociclib, Palbociclib, and Abemaciclib in ER+/HER2- EBC
PHASE2The 3 FDA-approved CDK4, 6 inhibitors, palbociclib, ribociclib, and abemcic...
Location
Department of Oncology, National Taiwan University Hospital
Neoadjuvant Treatment of Locally-advanced Breast Cancer Patients With Ribociclib and Letrozole
PHASE2Patients with locally advanced (stage III) breast cancer (LABC) are charact...
Location
Akershus University Hospital
Efficacy and Safety of CDK4/6 Inhibitors Combined With Endocrine Therapy in HR+/HER2- Neoadjuvant Therapy for Early Breast Cancer
PHASE2This is a single arm, open label, phase 2 trial aimed to investigate the ef...
Status
Active Not Recruiting
Location
No. 119 Zhuodaoquan South Road
Analysis of Circulating Tumor Markers in Blood
NAThe circulating tumoral biomarkers in the blood are the object of numerous ...
Location
Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle
Tailoring NEOadjuvant Therapy in Hormone Receptor Positive, HER2 Negative, Luminal Breast Cancer.
PHASE2The aim of this prospective, randomized, multicenter, open-label, phase II ...
Status
Active Not Recruiting
Location
Jeroen Bosch Ziekenhuis
Neadjuvant Multi-agent Chemotherapy or Letrozole Plus Ribociclib in Luminal B/HER2-negative Breast Cancer.
PHASE2CORALLEEN is a two-arm, randomized, multicentric study in postmenopausal wo...
Location
Hospital Clinic de Barcelona
Ribociclib in Hormone Receptor-positive, HER2-negative Early Breast Cancer With Residual Disease After Neoadjuvant Chemotherapy
PHASE3This is a multi-center, open-lable, prospective, randomized phase III clini...
Location
Affiliated Hospital of Guangdong Medical University